Practical Guidelines for the Diagnosis and Management of Calcium Urolithiasis

  • Charles Y. C. Pak
Part of the Topics in Bone and Mineral Disorders book series (TOHE)


While there has been a significant advancement in the urological management of patients with renal stones, many patients still undergo repeated urological procedures without examination of the cause of stone formation or a trial on a preventative medical regimen. In the light of recent advances in the understanding of the pathogenesis of nephrolithiasis, serious consideration should be given to the evaluation of patients with renal calculi in a search for the cause of urolithiasis. The value of such an evaluation derives from accumulating evidence that an appropriately selected treatment regimen may decrease the morbidity associated with this disease. 1,2


Uric Acid Primary Hyperparathyroidism Stone Formation Renal Tubular Acidosis Urinary Oxalate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pak, C. Y. C., Delea, C. S., and Bartter, F. C. 1974. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate. N. Engl. J. Med. 290: 175–180.PubMedCrossRefGoogle Scholar
  2. 2.
    Coe, F. L., and Raisen, L. 1973. Allopurinol treatment of uric acid disorders in calcium-stone formers. Lancet 1: 129–131.PubMedCrossRefGoogle Scholar
  3. 3.
    Pak, C. Y. C., Ohata, M., Lawrence, E. C., and Snyder, W. 1974. The hypercalciurias: Causes, parathyroid functions and diagnostic criteria. J. Clin. Invest. 54: 387–400.PubMedCrossRefGoogle Scholar
  4. 4.
    Pak, C. Y. C., Fetner, C., Townsend, J., Brinkley, L., Northcutt, C., Barilla, D. E., Kadesky, M., and Peters, P. 1977. Ambulatory evaluation of calcium urolithiasis: Comparison of results with those of inpatient evaluation. Am. J. Med. In press.Google Scholar
  5. 5.
    Griffith, D. P., and Musher, D. M. 1973. Prevention of infected urinary stones by urease inhibition. Invest. Urol. 11: 228–233.PubMedGoogle Scholar
  6. 6.
    Bartter, F. C., Lotz, M., Thier, S., Rosenberg, L. E., and Potts, J. T., Jr. 1965. Cystinuria: Combined clinical staff conference at the National Institutes of Health. Ann. Intern. Med. 62: 796–822.Google Scholar
  7. 7.
    Kaplan, R. A., Snyder, W. H., Stewart, A., and Pak, C. Y. C. 1976. Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 42: 415–426.PubMedCrossRefGoogle Scholar
  8. 8.
    Bone, H. G., III, Snyder, W. H., and Pak, C. Y. C. 1977. Diagnosis of hyperparathyroidism. Annu. Rev. Med. 28: 111–117.PubMedCrossRefGoogle Scholar
  9. 9.
    Earnest, D. L., Williams, H. E., and Admirand, W. H. 1975. A physicochemical basis for treatment of enteric hyperoxaluria. Trans. Assoc. Amer. Physicians 88: 224–234.Google Scholar
  10. 10.
    Coe, F. L., and Kavalach, A. G. 1974. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N. Engl. J. Med. 291: 1344–1350.PubMedCrossRefGoogle Scholar
  11. 11.
    Lamden, M. P., and Chrystowski, G. A. 1954. Urinary oxalate excretion by man following ascorbic acid ingestion. Proc. Soc. Exp. Biol. Med. 85:190– 192.Google Scholar
  12. 12.
    Seegmiller, J. E. 1968. Xanthine stone formation. Am. J. Med. 45: 780–783.PubMedCrossRefGoogle Scholar
  13. 13.
    Rao, D. S., Frame, B., Block, M. A., and Parfitt, A. M. 1977. Primary hyperparathyroidism: A cause of hypercalciuria and renal stones in patients with medullary sponge kidney. J. Am. Med. Assoc. 237: 1353–1355.CrossRefGoogle Scholar
  14. 14.
    Gremillion, D. H., Kee, J. W., and Mcintosh, D. A. 1977. Hyperparathyroidism and medullary sponge kidney: A chance relationship? J. Am. Med. Assoc. 237: 799–800.CrossRefGoogle Scholar
  15. 15.
    Pak, C. Y. C., Kaplan, R. A., Bone, H., Townsend, J., and Waters, O. 1975. A simple test for the diagnosis of absorptive, resorptive, and renal hypercalciurias. N. Engl. J. Med. 292: 497–500.PubMedCrossRefGoogle Scholar
  16. 16.
    Pak, C. Y. C., and Holt, K. 1976. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism 25: 665–673.PubMedCrossRefGoogle Scholar
  17. 17.
    Pak, C. Y. C., Waters, O., Arnold, L., Holt, K., Cox, C., and Barilla, D. 1977. Mechanism for calcium urolithiasis among patients with hyperuricosuria: Supersaturation of urine with respect to monosodium urate. J. Clin. Invest. 59: 426–431.PubMedCrossRefGoogle Scholar
  18. 18.
    Williams, H. E., and Smith, L. H., Jr. 1968. L-Glyceric aciduria: A new genetic variant of primary hyperoxaluria. N. Engl. J. Med. 278: 233–239.PubMedCrossRefGoogle Scholar
  19. 19.
    Hayashi, Y., Kaplan, R. A., and Pak, C. Y. C. 1975. Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine. Metabolism 24: 1273–1278.PubMedCrossRefGoogle Scholar
  20. 20.
    Morris, R. C., Jr. 1969. Renal tubular acidosis: Mechanisms, classification and implications. N. Engl. J. Med. 281: 1405–1413.PubMedCrossRefGoogle Scholar
  21. 21.
    Smith, L. H., Thomas, W. C., Jr., and Arnaud, C. D. 1973. Orthophosphate therapy in calcium renal lithiasis. In Urinary Calculi: Proceedings of the International Symposium on Renal Stone Research, Madrid, 1972. L. C. Delatte, A. Rapado, and A. Hodgkinson, Eds. Karger, Basel and New York, pp. 188–197.Google Scholar
  22. 22.
    Coe, F. L., Canterbury, J. M., Firpo, J. J., and Reiss, E. 1973. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J. Clin. Invest. 52: 134–142.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • Charles Y. C. Pak
    • 1
  1. 1.The University of Texas Health Science CenterDallasUSA

Personalised recommendations